Suzhou Genhouse Bio Co., Ltd.
Clinical trials sponsored by Suzhou Genhouse Bio Co., Ltd., explained in plain language.
-
New drug duo targets Hard-to-Treat cancers in phase 2 trial
Disease control Not yet recruitingThis study tests a combination of two experimental drugs (GH21 and D-1553) in 120 adults with advanced solid tumors that have a specific genetic change called KRASG12C. Participants must have already tried standard treatments or have no standard options, and have previously taken…
Phase: PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 09:50 UTC
-
New pill combo aims to starve cancer cells by cutting off growth signals
Disease control Not yet recruitingThis study tests two oral drugs, GH55 and GH21, taken together to treat advanced solid tumors that have certain gene changes (MAPK pathway). The drugs work by blocking signals that tell cancer cells to grow. About 152 adults whose cancer has not responded to standard treatments w…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC